| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
BTIG analyst Mark Massaro maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and raises the price target from $125 to $140.
Canaccord Genuity analyst Kyle Mikson initiates coverage on GeneDx Holdings (NASDAQ:WGS) with a Buy rating and announces Pri...
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and...